A Big Bonus from a Cholesterol-Buster?
When Mevacor, the first of a new class of cholesterol-lowering drugs known as statins, hit the market in 1987, doctors and patients were elated. Unlike other drugs available at the time, Mevacor was effective, had only minor but unpleasant side effects, and best of all, could be taken orally once a day.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Gulf of Mexico Oil Spill May Be Largest Since 2010 BP Disaster
- Billionaire Tom Barrack Throws Harvey Weinstein a Lifeline
- Everything Is Crazy and the Markets Aren’t Freaking Out
- Facebook Is Looking for Employees With National Security Clearances
- Kushners’ Control of Family’s NYC Crown Jewel Is Now in Jeopardy